Biowaived

Biopharmaceutics consultancy and dissolution laboratory services for pharma and biotech drug product development

Sandwich, United KingdomFounded 2024biowaived.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-07

About Biowaived

Biowaived provides biopharmaceutics consultancy and laboratory-based experimental support for drug product development. Its services cover biopharmaceutics risk management, dissolution method development and biorelevant dissolution testing, solubility studies, BCS biowaiver data packages, API physicochemical characterisation, and PBBM/PBPK and dissolution modelling using Siemens gPROMS Pharmaceutics.

Its customers are pharmaceutical and biotechnology companies that need to understand how a drug product will perform in patients across development, from preclinical work to clinical studies and regulatory submissions. Work is delivered as consultancy and dissolution work packages, typically beginning with a discussion of the project, followed by an agreed proposal.

The company is registered in the United Kingdom, with its registered seat in Sandwich, Kent, and was founded in 2024. Its team includes scientists in biopharmaceutics, formulation, analytical and materials sciences, and it operates a fully equipped laboratory with modelling capability.

Product: Biopharmaceutics consultancy, dissolution and solubility laboratory studies, BCS biowaiver data packages, and PBBM/PBPK modelling.

Jobs at Biowaived

No open positions listed right now.

More biotech & pharma companies

  • Blackfinbio

    Develops gene therapies for patients with rare and other central nervous system diseases
    Altrincham, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Blacksheep Sciences

    Engineering and product-development services for life science and biotech teams building instruments and microfluidic platforms
    Royston, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Blue Earth Diagnostics

    Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patients
    Oxford, United KingdomBiotech & pharmaFounded 2013101 open jobs
    New on EvolcSalary transparent
  • Blue Earth Therapeutics

    Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapies
    Oxford, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Bounce Biomedical

    Develops regenerative implants for patients with cartilage and bone injuries in joints
    Abingdon, United KingdomBiotech & pharmaFounded 2008
    New on Evolc
  • Bowmed Ibisqus

    Supplies generic injectable medicines to NHS hospitals and private healthcare providers in the UK
    Manchester, United KingdomBiotech & pharmaFounded 2007
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • ContentsquareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Privacy & consent

  • CookieScriptHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.